Boehringer Ingelheim
-
ZEISS, Boehringer Ingelheim join forces to develop early detection of eye diseases
The partnership brings together their leading expertise in ophthalmological technology, data analytics, algorithms and the development of first-in-class treatments to…
Read More » -
Boehringer Ingelheim ropes in Gagandeep Singh as MD and Head of Human Pharma for India
Singh succeeds Vani Manja, who moved to Boehringer Ingelheim UK in February 2023 Boehringer Ingelheim has appointed Gagandeep Singh as…
Read More » -
SPEVIGO bags breakthrough therapy designation in US for prevention of generalised pustular psoriasis flares
The designation follows the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA), which also recently…
Read More » -
Boehringer Ingelheim, 3T Biosciences to develop next gencancer immunotherapies
Boehringer Ingelheim will provide patient-derived TCR data to fuel 3T’s target discovery efforts to identify antigens using its 3T TRACE…
Read More » -
FDA approves BI’s treatment option for generalized pustular psoriasis flares in adults
SPEVIGO is a novel, selective antibody that blocks the activation of the interleukin-36 receptor (IL-36R) Boehringer Ingelheim announced that the…
Read More » -
Boehringer Ingelheim and A*STAR in global licensing agreement
Boehringer Ingelheim will be responsible for further research, preclinical and clinical development as well as commercialisation of targeted cancer therapies…
Read More » -
Boehringer Ingelheim’s Jardiance bags CDSCO approval
The drug is the first treatment for heart failure with preserved ejection fraction (HFpEF) in India Boehringer Ingelheim has received…
Read More » -
Boehringer Ingelheim launches Jardiance to treat heart failure
The company receives approval from CDSCO Boehringer Ingelheim has launched an additional heart failure indication for Jardiance (empagliflozin) in India.…
Read More » -
Boehringer Ingelheim allocates COVID relief fund in India
Euro 1 million package to focus on medical, sustenance support Boehringer Ingelheim is making available a euro one million COVID…
Read More » -
Boehringer Ingelheim India to sustain growth momentum in 2021
Focuses on partnerships in NCD management Boehringer Ingelheim India shared its roadmap of partnerships and patient access programmes to sustain…
Read More »